Status:
COMPLETED
Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients
Lead Sponsor:
AstraZeneca
Conditions:
Cough Variant Asthma
Eligibility:
All Genders
Up to 5 years
Brief Summary
This open label, non-interventional study is to show the efficacy of Pulmicort®Respules® in cough variant asthma in patient aged 5-year old or younger in outpatient department
Eligibility Criteria
Inclusion
- Provision of informed consent
- Patient who has been prescribed Pulmicort® Respules® according to physician's judgement, irrespective of the inclusion in the study.
- The usage of Pulmicort® Respules® follows local authorised package insert.
Exclusion
- Allergy to any ingredient of Pulmicort® Respules®
- With history of Leukotriene Modifier (LM) usage prior to 2 weeks of recruitment or following plan.
- Have used systemic/inhaled steroid prior to 2 weeks of recruitment
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
914 Patients enrolled
Trial Details
Trial ID
NCT00660114
Start Date
April 1 2008
End Date
March 1 2009
Last Update
May 28 2009
Active Locations (32)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Hefei, Anhui, China
2
Research Site
Beijing, Beijing Municipality, China
3
Research Site
Chongqing, Chongqing Municipality, China
4
Research Site
Quanzhou, Fujian, China